(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of YPEL5 mRNA] CTD PMID:31150632 (-)-demecolcine increases expression ISO YPEL5 (Homo sapiens) 6480464 Demecolcine results in increased expression of YPEL5 mRNA CTD PMID:23649840 (1->4)-beta-D-glucan multiple interactions ISO Ypel5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of YPEL5 mRNA CTD PMID:36331819 1,2-dimethylhydrazine decreases expression ISO Ypel5 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of YPEL5 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO YPEL5 (Homo sapiens) 6480464 Estradiol results in decreased expression of YPEL5 mRNA CTD PMID:16474171 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO YPEL5 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of YPEL5 mRNA CTD PMID:20106945 and PMID:21632981 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of YPEL5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of YPEL5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ypel5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of YPEL5 mRNA CTD PMID:21570461 2-hydroxypropanoic acid decreases expression ISO YPEL5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of YPEL5 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YPEL5 mRNA CTD PMID:28628672 5-aza-2'-deoxycytidine affects expression ISO YPEL5 (Homo sapiens) 6480464 Decitabine affects the expression of YPEL5 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of YPEL5 mRNA CTD PMID:30047161 acrolein multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of YPEL5 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of YPEL5 mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of YPEL5 mRNA CTD PMID:28959563 acrylamide increases expression ISO YPEL5 (Homo sapiens) 6480464 Acrylamide results in increased expression of YPEL5 mRNA CTD PMID:32763439 aflatoxin B1 increases expression ISO Ypel5 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of YPEL5 mRNA CTD PMID:19770486 all-trans-retinoic acid increases expression ISO YPEL5 (Homo sapiens) 6480464 Tretinoin results in increased expression of YPEL5 mRNA CTD PMID:23830798 and PMID:33167477 alpha-pinene multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of YPEL5 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of YPEL5 mRNA CTD PMID:32699268 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of YPEL5 mRNA CTD PMID:30047161 arsenite(3-) multiple interactions ISO YPEL5 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to YPEL5 mRNA] CTD PMID:32406909 arsenous acid multiple interactions ISO YPEL5 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to YPEL5 protein] CTD PMID:26598702 atrazine increases expression ISO YPEL5 (Homo sapiens) 6480464 Atrazine results in increased expression of YPEL5 mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO Ypel5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of YPEL5 mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO YPEL5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of YPEL5 5' UTR and Benzo(a)pyrene affects the methylation of YPEL5 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO Ypel5 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of YPEL5 mRNA CTD PMID:27858113 benzo[a]pyrene diol epoxide I decreases expression ISO YPEL5 (Homo sapiens) 6480464 7 more ... CTD PMID:20018196 benzo[a]pyrene diol epoxide I increases expression ISO YPEL5 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene multiple interactions ISO Ypel5 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of YPEL5 mRNA CTD PMID:27858113 bisphenol A decreases expression ISO YPEL5 (Homo sapiens) 6480464 bisphenol A results in decreased expression of YPEL5 mRNA CTD PMID:16474171 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of YPEL5 mRNA CTD PMID:25181051 bisphenol A increases expression ISO Ypel5 (Mus musculus) 6480464 bisphenol A results in increased expression of YPEL5 mRNA CTD PMID:26063408 bisphenol F multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of YPEL5 gene and [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YPEL5 mRNA CTD PMID:28628672 and PMID:31601247 bortezomib increases expression ISO YPEL5 (Homo sapiens) 6480464 Bortezomib results in increased expression of YPEL5 mRNA CTD PMID:20977926 buspirone increases expression EXP 6480464 Buspirone results in increased expression of YPEL5 mRNA CTD PMID:24136188 cantharidin decreases expression ISO Ypel5 (Mus musculus) 6480464 Cantharidin results in decreased expression of YPEL5 mRNA CTD PMID:36907384 chloropicrin increases expression ISO YPEL5 (Homo sapiens) 6480464 chloropicrin results in increased expression of YPEL5 mRNA CTD PMID:26352163 chrysene multiple interactions ISO Ypel5 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of YPEL5 mRNA CTD PMID:27858113 ciguatoxin CTX1B affects expression ISO Ypel5 (Mus musculus) 6480464 Ciguatoxins affects the expression of YPEL5 mRNA CTD PMID:18353800 cisplatin affects expression ISO YPEL5 (Homo sapiens) 6480464 Cisplatin affects the expression of YPEL5 mRNA CTD PMID:23300844 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of YPEL5 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO YPEL5 (Homo sapiens) 6480464 cobaltous chloride results in increased expression of YPEL5 mRNA CTD PMID:19320972 and PMID:19376846 copper atom multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of YPEL5 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in increased expression of YPEL5 mRNA CTD PMID:20971185 copper(II) sulfate increases expression ISO YPEL5 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of YPEL5 mRNA CTD PMID:19549813 coumestrol multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 coumestrol decreases expression ISO YPEL5 (Homo sapiens) 6480464 Coumestrol results in decreased expression of YPEL5 mRNA CTD PMID:19167446 cyclosporin A affects expression ISO YPEL5 (Homo sapiens) 6480464 Cyclosporine affects the expression of YPEL5 mRNA CTD PMID:25562108 dexamethasone multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YPEL5 mRNA CTD PMID:28628672 diarsenic trioxide multiple interactions ISO YPEL5 (Homo sapiens) 6480464 Arsenic Trioxide inhibits the reaction [4-aminophenylarsenoxide binds to YPEL5 protein] CTD PMID:26598702 dicrotophos decreases expression ISO YPEL5 (Homo sapiens) 6480464 dicrotophos results in decreased expression of YPEL5 mRNA CTD PMID:28302478 diethyl maleate increases expression ISO Ypel5 (Mus musculus) 6480464 diethyl maleate results in increased expression of YPEL5 mRNA CTD PMID:25270620 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of YPEL5 mRNA CTD PMID:29391264 Enterolactone multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of YPEL5 mRNA CTD PMID:19167446 epoxiconazole increases expression ISO Ypel5 (Mus musculus) 6480464 epoxiconazole results in increased expression of YPEL5 mRNA CTD PMID:35436446 ethanol increases expression ISO Ypel5 (Mus musculus) 6480464 Ethanol results in increased expression of YPEL5 mRNA CTD PMID:30319688 ethanol affects splicing ISO Ypel5 (Mus musculus) 6480464 Ethanol affects the splicing of YPEL5 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO YPEL5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in increased expression of YPEL5 mRNA CTD PMID:23649840 flutamide increases expression EXP 6480464 Flutamide results in increased expression of YPEL5 mRNA CTD PMID:24136188 formaldehyde increases expression ISO YPEL5 (Homo sapiens) 6480464 Formaldehyde results in increased expression of YPEL5 mRNA CTD PMID:23649840 fulvestrant multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of YPEL5 gene CTD PMID:31601247 genistein decreases expression ISO YPEL5 (Homo sapiens) 6480464 Genistein results in decreased expression of YPEL5 mRNA CTD PMID:16474171 and PMID:23019147 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of YPEL5 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of YPEL5 mRNA CTD PMID:24136188 hydrogen peroxide affects expression ISO YPEL5 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of YPEL5 mRNA CTD PMID:20044591 indometacin multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of YPEL5 mRNA CTD PMID:28628672 ketamine increases expression EXP 6480464 Ketamine results in increased expression of YPEL5 mRNA CTD PMID:20080153 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of YPEL5 mRNA CTD PMID:30047161 methyl methanesulfonate increases expression ISO YPEL5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of YPEL5 mRNA CTD PMID:23649840 N(4)-hydroxycytidine decreases expression ISO Ypel5 (Mus musculus) 6480464 N(4)-hydroxycytidine results in decreased expression of YPEL5 mRNA CTD PMID:37748715 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of YPEL5 mRNA CTD PMID:24136188 niclosamide increases expression ISO YPEL5 (Homo sapiens) 6480464 Niclosamide results in increased expression of YPEL5 mRNA CTD PMID:36318118 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of YPEL5 mRNA CTD PMID:24136188 ozone multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of YPEL5 mRNA more ... CTD PMID:32699268 and PMID:35430440 paracetamol increases expression ISO YPEL5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of YPEL5 mRNA CTD PMID:21420995 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of YPEL5 mRNA CTD PMID:33387578 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 pentachlorophenol increases expression ISO Ypel5 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of YPEL5 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid multiple interactions ISO Ypel5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of YPEL5 mRNA CTD PMID:36331819 phorone affects expression EXP 6480464 phorone affects the expression of YPEL5 mRNA CTD PMID:18198479 pirinixic acid increases expression ISO Ypel5 (Mus musculus) 6480464 pirinixic acid results in increased expression of YPEL5 mRNA CTD PMID:17426115 rac-lactic acid decreases expression ISO YPEL5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of YPEL5 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in decreased expression of YPEL5 mRNA CTD PMID:19167446 silicon dioxide decreases expression ISO YPEL5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of YPEL5 mRNA CTD PMID:25895662 sodium arsenite increases expression ISO Ypel5 (Mus musculus) 6480464 sodium arsenite results in increased expression of YPEL5 mRNA CTD PMID:25270620 sodium arsenite decreases expression ISO YPEL5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of YPEL5 mRNA CTD PMID:28595984 and PMID:34032870 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of YPEL5 mRNA CTD PMID:30047161 temozolomide decreases expression ISO YPEL5 (Homo sapiens) 6480464 Temozolomide results in decreased expression of YPEL5 mRNA CTD PMID:31758290 tetrachloromethane affects expression ISO Ypel5 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of YPEL5 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO Ypel5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of YPEL5 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of YPEL5 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of YPEL5 mRNA CTD PMID:31150632 tetraphene multiple interactions ISO Ypel5 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of YPEL5 mRNA CTD PMID:27858113 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of YPEL5 mRNA CTD PMID:34492290 trovafloxacin increases expression EXP 6480464 trovafloxacin results in increased expression of YPEL5 mRNA CTD PMID:24136188 tunicamycin increases expression ISO YPEL5 (Homo sapiens) 6480464 Tunicamycin results in increased expression of YPEL5 mRNA CTD PMID:22378314 urethane increases expression ISO YPEL5 (Homo sapiens) 6480464 Urethane results in increased expression of YPEL5 mRNA CTD PMID:28818685 valproic acid increases expression ISO YPEL5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of YPEL5 mRNA CTD PMID:19101580 valproic acid affects expression ISO YPEL5 (Homo sapiens) 6480464 Valproic Acid affects the expression of YPEL5 mRNA CTD PMID:25979313 valproic acid decreases expression ISO YPEL5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of YPEL5 mRNA CTD PMID:23179753 valproic acid increases expression ISO Ypel5 (Mus musculus) 6480464 Valproic Acid results in increased expression of YPEL5 mRNA CTD PMID:19136453 vincristine increases expression ISO YPEL5 (Homo sapiens) 6480464 Vincristine results in increased expression of YPEL5 mRNA CTD PMID:23649840 zinc atom multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of YPEL5 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO YPEL5 (Homo sapiens) 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of YPEL5 mRNA CTD PMID:18593933